Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function

Journal of the American College of Cardiology

Volumn 25, Issue 2, 1995, Pages 424-430

  Gottdiener, John S ^a   Livengood, Sue V ^a   Meyer, Patricia S ^a   Chase, Gary A ^a  

^a Division of Cardiology Office of Consulting Biostatistics Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0028877694     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)00375-Z     Document Type: Article

References (40)

1. The reversal of left ventricular hypertrophy with control of blood pressure in experimental hypertension
2. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy
3. The effects of antihypertensive therapy on left ventricular mass in elderly patients
4. Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension
5. Ventricular arrhythmias in hypertensive left ventricular hypertrophy: relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis
6. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
7. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertesion
8. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
9. Left ventricular hypertrophy further evidence of risk
10. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol
11. Improved left ventricular systolic and diastolic function after regression of cardiac hypertrophy treatment withdrawal, and redevelopment of hypertension
12. Effects of fosinopril on cardiac function in patients with hypertension: radionuclide assessment of left ventricular systolic and diastolic performance
13. Cardiac hypertrophy and antihypertensive therapy
14. Standardization in the measurement of left ventricular wall mass; two-dimensional echocardiography
15. Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography
16. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results
17. Considerations in the standardization of measurement of left ventricular myocardial mass by two-dimensional echocardiography
18. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings
19. Echocardiographic determination of left ventricular mass in man
20. Measurement of left ventricular wall thickness and mass by echocardiography
21. Effect of autonomic blockade, postural changes, and isometric exercise on Doppler indices of diastolic left ventricular function
22. Left ventricular mass, diastolic dysfunction and hypertension
23. Echocardiographic Doppler evaluation of left ventricular diastolic function
24. Doppler evaluation of left ventricular diastolic function
25. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographics measurements
26. The measurement of observer agreement for categorical data
27. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension
28. Echocardiographic assessment of the left ventricle in hypertension: perspectives on epidemiologic studies and clinical trials
29. Reproducibility of echocardiographic left ventricular measurements
30. Accuracy and reproducibility of new M-mode recommendations for measuring left ventricular dimensions
31. Reproducibility of quantitative two-dimensional echocardiography
32. Reproducibility of echocardiography: a study evaluating the variability of serial echocardiographic measurements
33. Year-to-year variability of echocardiographic measurementsin normal subjects
34. Magnetic resonance imaging as a noninvasive standard for the quantitative evaluation of left ventricular mass ischemia and infarction
35. Estimation of human myocardial mass with MR imaging
36. Left ventricular mass quantitation using single-phase cardiac magnetic resonance imaging
37. Three-dimensional echocardiography. Advances for measurement of ventricular volume and mass